サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566973

カスタム抗体サービス市場：サービス別、タイプ別、供給源別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年

Custom Antibody Services Market By Service , By Type By Source By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 233 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.84円
カスタム抗体サービス市場：サービス別、タイプ別、供給源別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 233 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

カスタム抗体サービス市場

カスタム抗体サービス市場は、2023年に6億米ドルと評価され、2024～2033年にかけてCAGR 8.7%で成長し、2033年には14億米ドルに達すると予測されています。

カスタム抗体サービスでは、ユーザーの要望に応じて抗体を作製します。抗体は、診断、研究、治療目的に合わせて特別に調整されます。カスタム抗体サービスを利用する主要利点は、抗原に対する抗体の特異性を達成できることであり、その結果、信頼性の高い実験結果が得られます。さらに、抗体にさまざまな改変を加えることができる柔軟性が、カスタム抗体サービスのメリットを顧客にアピールしています。

標的治療のための個別化医療の人気の高まりは、医療セグメントでのカスタム抗体サービスの採用を増加させています。また、製薬会社やバイオテクノロジー企業が研究開発活動の強化のために支出を急増させていることも、市場の成長を大きく後押ししています。カスタム抗体サービス市場の将来は、リコンビナント技術と新規抗体動向によって再定義されると予想されます。AIとMLアルゴリズムは、抗体の設計を支援し、単一ドメイン抗体、二重特異性抗体、抗体断片などの次世代抗体を開発する態勢を整えています。

しかし、抗体作製コストの高さと開発期間の長期化が、カスタム抗体サービス市場の成長を妨げています。さらに、抗体の認可のために確立された品質管理措置やバリデーションプロセスは、非常に厳格で時間がかかります。このような基準に効率的に準拠することは、市場の成長を遅らせる。これとは対照的に、医薬品開発と研究開発への投資が増加していることから、カスタム抗体サービス市場はいくつかの有利な成長機会を確認することになると予想されています。世界のデータ・ビジネスインテリジェンスプラットフォームであるStatistaによると、米国は2022年に6,030億米ドルを医薬品に投じると推定されています。さらに、米国の製薬企業は収益の約21％を研究開発活動に費やしています。こうした支出は、カスタム抗体サービス市場の将来が有望であることを示しています。

セグメント別レビュー

カスタム抗体サービス市場は、サービス、タイプ、供給源、用途、エンドユーザー、地域に区分されます。サービス別では、市場は抗体開拓、抗体作製・精製、抗体セグメント化・標識に分けられます。タイプ別では、モノクローナル抗体、ポリクローナル抗体、組み換え抗体、その他に分類されます。供給源により、マウス、ウサギ、その他に分類されます。用途別では、腫瘍学、感染症、神経学、免疫学、心血管疾患、その他に分類されます。エンドユーザー別では、製薬・バイオテクノロジー企業、学術・研究機関、その他に分類されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されています。

主要調査結果

サービス別では、抗体開発セグメントが2023年の市場を独占しました。

タイプ別では、モノクローナル抗体セグメントが2023年の市場の主要株主でした。

供給源別では、ウサギセグメントが2023年の市場で高いシェアを占めました。

用途別では、感染症セグメントが2023年の市場で高いシェアを占めました。

エンドユーザー別では、製薬・バイオテクノロジー企業が2023年の市場で高いシェアを獲得しました。

地域別では、北米が2023年に最も高い収益を上げました。

本レポートで可能なカスタマイズ（追加費用とスケジュールがあります。）

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡大リスト
  • 過去の市場データ
  • 主要参入企業の詳細（所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 カスタム抗体サービス市場：サービス別

  • 市場概要
  • 抗体開発
  • 抗体の生産と精製
  • 抗体のセグメント化と標識化

第5章 カスタム抗体サービス市場：タイプ別

  • 市場概要
  • モノクローナル抗体
  • ポリクローナル抗体
  • 組み換え抗体
  • その他

第6章 カスタム抗体サービス市場：供給源別

  • 市場概要
  • マウス
  • ウサギ
  • その他

第7章 カスタム抗体サービス市場：用途別

  • 市場概要
  • 腫瘍学
  • 感染症
  • 神経学
  • 免疫学
  • 心血管疾患
  • その他

第8章 カスタム抗体サービス市場：エンドユーザー別

  • 市場概要
  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • その他

第9章 カスタム抗体サービス市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国のカスタム抗体サービス市場
    • カナダのカスタム抗体サービス市場
    • メキシコのカスタム抗体サービス市場
  • 欧州
    • 主要市場動向と機会
    • ドイツのカスタム抗体サービス市場
    • フランスのカスタム抗体サービス市場
    • 英国のカスタム抗体サービス市場
    • イタリアのカスタム抗体サービス市場
    • スペインのカスタム抗体サービス市場
    • その他の欧州のカスタム抗体サービス市場
  • アジア太平洋
    • 主要市場動向と機会
    • 日本のカスタム抗体サービス市場
    • 中国のカスタム抗体サービス市場
    • インドのカスタム抗体サービス市場
    • オーストラリアの抗体サービス市場
    • 韓国のカスタム抗体サービス市場
    • その他のアジア太平洋のカスタム抗体サービス市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルのカスタム抗体サービス市場
    • サウジアラビアのカスタム抗体サービス市場
    • 南アフリカのカスタム抗体サービス市場
    • その他のラテンアメリカ・中東・アフリカのカスタム抗体サービス市場

第10章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第11章 企業プロファイル

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Sino Biological, Inc.
  • Bio-Rad Laboratories, Inc
  • Kaneka Eurogentec S.A.
  • YenZym Antibodies, LLC.
  • OriGene Technologies, Inc.
  • Laboratory Corporation of America Holdings.
  • GenScript
目次
Product Code: A324397

Custom Antibody Services Market

The custom antibody services market was valued at $0.6 billion in 2023 and is projected to reach $1.4 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.

Custom antibody services involve producing distinguished antibodies as per user requirements. The antibodies are specifically tailored for diagnostic, research, and therapeutic purposes. A key benefit of utilizing custom antibody services is the attainability of specificity in antibodies against antigens, resulting in improved & reliable experimental results. In addition, the flexibility of integrating different modifications into the antibodies attracts clients to benefit from the custom antibody services.

Increase in the popularity of personalized medicine for targeted therapies is rising the adoption of custom antibody services in the healthcare field. In addition, with surging expenditure in the pharmaceutical and biotech sectors for the strengthening of their R&D activities, the growth of the market is being driven considerably. The future of the custom antibody services market is anticipated to be redefined by recombinant technology and novel antibody trends. AI and ML algorithm are poised to assist in the designing of antibodies and develop next-generational antibodies such as single domain antibodies, bispecific antibodies, and antibody fragments.

However, the high cost of antibody production and extended development time hamper the growth of the custom antibody services market. In addition, the quality control measures and validation processes established for the approval of antibodies are highly rigorous and time-consuming. Efficient compliance with such standards delays the growth of the market. Contrarily, with rising investments on drug development and R&D, the custom antibody services market is anticipated to witness several lucrative growth opportunities. According to Statista, a global data and business intelligence platform, the U.S. spent an estimated amount of $603 billion on medicine in 2022. Furthermore, pharma companies in the U.S. spend approximately 21% of their revenue on R&D activities. Such expenditures indicate a promising future for the custom antibody services market.

Segment Review

The custom antibody services market is segmented into service, type, source, application, end user, and region. On the basis of service, the market is divided into antibody development, antibody production & purification, and antibody fragmentation & labeling. As per type, it is classified into monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and others. Depending on source, it is categorized into mice, rabbit, and others. According to application, it is divided into oncology, infectious diseases, neurology, immunology, cardiovascular diseases, and others. By end user, it is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of service, the antibody development segment dominated the market in 2023.

As per type, the monoclonal antibodies segment was the major shareholder of the market in 2023.

Depending on source, the rabbit segment held a high share in the market in 2023.

According to application, the infectious diseases segment accounted for a high share in the market in 2023.

By end user, the pharmaceutical & biotechnology companies segment acquired a high stake in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players of the global custom antibody services market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Sino Biological, Inc., Bio-Rad Laboratories, Inc, Kaneka Eurogentec S.A., YenZym Antibodies, LLC., OriGene Technologies, Inc., Laboratory Corporation of America Holdings., and GenScript. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Service

  • Antibody Development
  • Antibody Production and Purification
  • Antibody Fragmentation and Labeling

By Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
  • Others

By Source

  • Mice
  • Rabbit
  • Others

By Application

  • Oncology
  • Infectious Diseases
  • Neurology
  • Immunology
  • Cardiovascular Diseases
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Sino Biological, Inc.
    • Bio-Rad Laboratories, Inc
    • Kaneka Eurogentec S.A.
    • YenZym Antibodies, LLC.
    • OriGene Technologies, Inc.
    • Laboratory Corporation of America Holdings.
    • GenScript

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Service
  • 4.2. Antibody Development
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Antibody Production And Purification
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Antibody Fragmentation And Labeling
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: CUSTOM ANTIBODY SERVICES MARKET, BY TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Type
  • 5.2. Monoclonal Antibodies
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Polyclonal Antibodies
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Recombinant Antibodies
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Source
  • 6.2. Mice
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Rabbit
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Application
  • 7.2. Oncology
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Infectious Diseases
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Neurology
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Immunology
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country
  • 7.6. Cardiovascular Diseases
    • 7.6.1. Key Market Trends, Growth Factors and Opportunities
    • 7.6.2. Market Size and Forecast, By Region
    • 7.6.3. Market Share Analysis, By Country
  • 7.7. Others
    • 7.7.1. Key Market Trends, Growth Factors and Opportunities
    • 7.7.2. Market Size and Forecast, By Region
    • 7.7.3. Market Share Analysis, By Country

CHAPTER 8: CUSTOM ANTIBODY SERVICES MARKET, BY END USER

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By End User
  • 8.2. Pharmaceutical And Biotechnology Companies
    • 8.2.1. Key Market Trends, Growth Factors and Opportunities
    • 8.2.2. Market Size and Forecast, By Region
    • 8.2.3. Market Share Analysis, By Country
  • 8.3. Academic And Research Institutes
    • 8.3.1. Key Market Trends, Growth Factors and Opportunities
    • 8.3.2. Market Size and Forecast, By Region
    • 8.3.3. Market Share Analysis, By Country
  • 8.4. Others
    • 8.4.1. Key Market Trends, Growth Factors and Opportunities
    • 8.4.2. Market Size and Forecast, By Region
    • 8.4.3. Market Share Analysis, By Country

CHAPTER 9: CUSTOM ANTIBODY SERVICES MARKET, BY REGION

  • 9.1. Market Overview
    • 9.1.1 Market Size and Forecast, By Region
  • 9.2. North America
    • 9.2.1. Key Market Trends and Opportunities
    • 9.2.2. Market Size and Forecast, By Service
    • 9.2.3. Market Size and Forecast, By Type
    • 9.2.4. Market Size and Forecast, By Source
    • 9.2.5. Market Size and Forecast, By Application
    • 9.2.6. Market Size and Forecast, By End User
    • 9.2.7. Market Size and Forecast, By Country
    • 9.2.8. U.S. Custom Antibody Services Market
      • 9.2.8.1. Market Size and Forecast, By Service
      • 9.2.8.2. Market Size and Forecast, By Type
      • 9.2.8.3. Market Size and Forecast, By Source
      • 9.2.8.4. Market Size and Forecast, By Application
      • 9.2.8.5. Market Size and Forecast, By End User
    • 9.2.9. Canada Custom Antibody Services Market
      • 9.2.9.1. Market Size and Forecast, By Service
      • 9.2.9.2. Market Size and Forecast, By Type
      • 9.2.9.3. Market Size and Forecast, By Source
      • 9.2.9.4. Market Size and Forecast, By Application
      • 9.2.9.5. Market Size and Forecast, By End User
    • 9.2.10. Mexico Custom Antibody Services Market
      • 9.2.10.1. Market Size and Forecast, By Service
      • 9.2.10.2. Market Size and Forecast, By Type
      • 9.2.10.3. Market Size and Forecast, By Source
      • 9.2.10.4. Market Size and Forecast, By Application
      • 9.2.10.5. Market Size and Forecast, By End User
  • 9.3. Europe
    • 9.3.1. Key Market Trends and Opportunities
    • 9.3.2. Market Size and Forecast, By Service
    • 9.3.3. Market Size and Forecast, By Type
    • 9.3.4. Market Size and Forecast, By Source
    • 9.3.5. Market Size and Forecast, By Application
    • 9.3.6. Market Size and Forecast, By End User
    • 9.3.7. Market Size and Forecast, By Country
    • 9.3.8. Germany Custom Antibody Services Market
      • 9.3.8.1. Market Size and Forecast, By Service
      • 9.3.8.2. Market Size and Forecast, By Type
      • 9.3.8.3. Market Size and Forecast, By Source
      • 9.3.8.4. Market Size and Forecast, By Application
      • 9.3.8.5. Market Size and Forecast, By End User
    • 9.3.9. France Custom Antibody Services Market
      • 9.3.9.1. Market Size and Forecast, By Service
      • 9.3.9.2. Market Size and Forecast, By Type
      • 9.3.9.3. Market Size and Forecast, By Source
      • 9.3.9.4. Market Size and Forecast, By Application
      • 9.3.9.5. Market Size and Forecast, By End User
    • 9.3.10. UK Custom Antibody Services Market
      • 9.3.10.1. Market Size and Forecast, By Service
      • 9.3.10.2. Market Size and Forecast, By Type
      • 9.3.10.3. Market Size and Forecast, By Source
      • 9.3.10.4. Market Size and Forecast, By Application
      • 9.3.10.5. Market Size and Forecast, By End User
    • 9.3.11. Italy Custom Antibody Services Market
      • 9.3.11.1. Market Size and Forecast, By Service
      • 9.3.11.2. Market Size and Forecast, By Type
      • 9.3.11.3. Market Size and Forecast, By Source
      • 9.3.11.4. Market Size and Forecast, By Application
      • 9.3.11.5. Market Size and Forecast, By End User
    • 9.3.12. Spain Custom Antibody Services Market
      • 9.3.12.1. Market Size and Forecast, By Service
      • 9.3.12.2. Market Size and Forecast, By Type
      • 9.3.12.3. Market Size and Forecast, By Source
      • 9.3.12.4. Market Size and Forecast, By Application
      • 9.3.12.5. Market Size and Forecast, By End User
    • 9.3.13. Rest of Europe Custom Antibody Services Market
      • 9.3.13.1. Market Size and Forecast, By Service
      • 9.3.13.2. Market Size and Forecast, By Type
      • 9.3.13.3. Market Size and Forecast, By Source
      • 9.3.13.4. Market Size and Forecast, By Application
      • 9.3.13.5. Market Size and Forecast, By End User
  • 9.4. Asia-Pacific
    • 9.4.1. Key Market Trends and Opportunities
    • 9.4.2. Market Size and Forecast, By Service
    • 9.4.3. Market Size and Forecast, By Type
    • 9.4.4. Market Size and Forecast, By Source
    • 9.4.5. Market Size and Forecast, By Application
    • 9.4.6. Market Size and Forecast, By End User
    • 9.4.7. Market Size and Forecast, By Country
    • 9.4.8. Japan Custom Antibody Services Market
      • 9.4.8.1. Market Size and Forecast, By Service
      • 9.4.8.2. Market Size and Forecast, By Type
      • 9.4.8.3. Market Size and Forecast, By Source
      • 9.4.8.4. Market Size and Forecast, By Application
      • 9.4.8.5. Market Size and Forecast, By End User
    • 9.4.9. China Custom Antibody Services Market
      • 9.4.9.1. Market Size and Forecast, By Service
      • 9.4.9.2. Market Size and Forecast, By Type
      • 9.4.9.3. Market Size and Forecast, By Source
      • 9.4.9.4. Market Size and Forecast, By Application
      • 9.4.9.5. Market Size and Forecast, By End User
    • 9.4.10. India Custom Antibody Services Market
      • 9.4.10.1. Market Size and Forecast, By Service
      • 9.4.10.2. Market Size and Forecast, By Type
      • 9.4.10.3. Market Size and Forecast, By Source
      • 9.4.10.4. Market Size and Forecast, By Application
      • 9.4.10.5. Market Size and Forecast, By End User
    • 9.4.11. Australia Custom Antibody Services Market
      • 9.4.11.1. Market Size and Forecast, By Service
      • 9.4.11.2. Market Size and Forecast, By Type
      • 9.4.11.3. Market Size and Forecast, By Source
      • 9.4.11.4. Market Size and Forecast, By Application
      • 9.4.11.5. Market Size and Forecast, By End User
    • 9.4.12. South Korea Custom Antibody Services Market
      • 9.4.12.1. Market Size and Forecast, By Service
      • 9.4.12.2. Market Size and Forecast, By Type
      • 9.4.12.3. Market Size and Forecast, By Source
      • 9.4.12.4. Market Size and Forecast, By Application
      • 9.4.12.5. Market Size and Forecast, By End User
    • 9.4.13. Rest of Asia-Pacific Custom Antibody Services Market
      • 9.4.13.1. Market Size and Forecast, By Service
      • 9.4.13.2. Market Size and Forecast, By Type
      • 9.4.13.3. Market Size and Forecast, By Source
      • 9.4.13.4. Market Size and Forecast, By Application
      • 9.4.13.5. Market Size and Forecast, By End User
  • 9.5. LAMEA
    • 9.5.1. Key Market Trends and Opportunities
    • 9.5.2. Market Size and Forecast, By Service
    • 9.5.3. Market Size and Forecast, By Type
    • 9.5.4. Market Size and Forecast, By Source
    • 9.5.5. Market Size and Forecast, By Application
    • 9.5.6. Market Size and Forecast, By End User
    • 9.5.7. Market Size and Forecast, By Country
    • 9.5.8. Brazil Custom Antibody Services Market
      • 9.5.8.1. Market Size and Forecast, By Service
      • 9.5.8.2. Market Size and Forecast, By Type
      • 9.5.8.3. Market Size and Forecast, By Source
      • 9.5.8.4. Market Size and Forecast, By Application
      • 9.5.8.5. Market Size and Forecast, By End User
    • 9.5.9. Saudi Arabia Custom Antibody Services Market
      • 9.5.9.1. Market Size and Forecast, By Service
      • 9.5.9.2. Market Size and Forecast, By Type
      • 9.5.9.3. Market Size and Forecast, By Source
      • 9.5.9.4. Market Size and Forecast, By Application
      • 9.5.9.5. Market Size and Forecast, By End User
    • 9.5.10. South Africa Custom Antibody Services Market
      • 9.5.10.1. Market Size and Forecast, By Service
      • 9.5.10.2. Market Size and Forecast, By Type
      • 9.5.10.3. Market Size and Forecast, By Source
      • 9.5.10.4. Market Size and Forecast, By Application
      • 9.5.10.5. Market Size and Forecast, By End User
    • 9.5.11. Rest of LAMEA Custom Antibody Services Market
      • 9.5.11.1. Market Size and Forecast, By Service
      • 9.5.11.2. Market Size and Forecast, By Type
      • 9.5.11.3. Market Size and Forecast, By Source
      • 9.5.11.4. Market Size and Forecast, By Application
      • 9.5.11.5. Market Size and Forecast, By End User

CHAPTER 10: COMPETITIVE LANDSCAPE

  • 10.1. Introduction
  • 10.2. Top Winning Strategies
  • 10.3. Product Mapping of Top 10 Player
  • 10.4. Competitive Dashboard
  • 10.5. Competitive Heatmap
  • 10.6. Top Player Positioning, 2023

CHAPTER 11: COMPANY PROFILES

  • 11.1. Thermo Fisher Scientific Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Key Executives
    • 11.1.3. Company Snapshot
    • 11.1.4. Operating Business Segments
    • 11.1.5. Product Portfolio
    • 11.1.6. Business Performance
    • 11.1.7. Key Strategic Moves and Developments
  • 11.2. Merck KGaA
    • 11.2.1. Company Overview
    • 11.2.2. Key Executives
    • 11.2.3. Company Snapshot
    • 11.2.4. Operating Business Segments
    • 11.2.5. Product Portfolio
    • 11.2.6. Business Performance
    • 11.2.7. Key Strategic Moves and Developments
  • 11.3. Agilent Technologies, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Key Executives
    • 11.3.3. Company Snapshot
    • 11.3.4. Operating Business Segments
    • 11.3.5. Product Portfolio
    • 11.3.6. Business Performance
    • 11.3.7. Key Strategic Moves and Developments
  • 11.4. Sino Biological, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Key Executives
    • 11.4.3. Company Snapshot
    • 11.4.4. Operating Business Segments
    • 11.4.5. Product Portfolio
    • 11.4.6. Business Performance
    • 11.4.7. Key Strategic Moves and Developments
  • 11.5. Bio-Rad Laboratories, Inc
    • 11.5.1. Company Overview
    • 11.5.2. Key Executives
    • 11.5.3. Company Snapshot
    • 11.5.4. Operating Business Segments
    • 11.5.5. Product Portfolio
    • 11.5.6. Business Performance
    • 11.5.7. Key Strategic Moves and Developments
  • 11.6. Kaneka Eurogentec S.A.
    • 11.6.1. Company Overview
    • 11.6.2. Key Executives
    • 11.6.3. Company Snapshot
    • 11.6.4. Operating Business Segments
    • 11.6.5. Product Portfolio
    • 11.6.6. Business Performance
    • 11.6.7. Key Strategic Moves and Developments
  • 11.7. YenZym Antibodies, LLC.
    • 11.7.1. Company Overview
    • 11.7.2. Key Executives
    • 11.7.3. Company Snapshot
    • 11.7.4. Operating Business Segments
    • 11.7.5. Product Portfolio
    • 11.7.6. Business Performance
    • 11.7.7. Key Strategic Moves and Developments
  • 11.8. OriGene Technologies, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Key Executives
    • 11.8.3. Company Snapshot
    • 11.8.4. Operating Business Segments
    • 11.8.5. Product Portfolio
    • 11.8.6. Business Performance
    • 11.8.7. Key Strategic Moves and Developments
  • 11.9. Laboratory Corporation of America Holdings.
    • 11.9.1. Company Overview
    • 11.9.2. Key Executives
    • 11.9.3. Company Snapshot
    • 11.9.4. Operating Business Segments
    • 11.9.5. Product Portfolio
    • 11.9.6. Business Performance
    • 11.9.7. Key Strategic Moves and Developments
  • 11.10. GenScript
    • 11.10.1. Company Overview
    • 11.10.2. Key Executives
    • 11.10.3. Company Snapshot
    • 11.10.4. Operating Business Segments
    • 11.10.5. Product Portfolio
    • 11.10.6. Business Performance
    • 11.10.7. Key Strategic Moves and Developments